Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources required for performing infusions. An ebolavirus therapeutic administered via intramuscular (IM) injection would reduce the burdens...

Full description

Bibliographic Details
Main Authors: Erin Kuang, Robert W. Cross, Maria McCavitt-Malvido, Dafna M. Abelson, Viktoriya Borisevich, Lauren Stuart, Krystle N. Agans, Neil Mlakar, Arumugapradeep Marimuthu, Daniel J. Deer, William S. Shestowsky, Do Kim, Joan B. Geisbert, Larry Zeitlin, Crystal L. Moyer, Chad J. Roy, Thomas W. Geisbert, Zachary A. Bornholdt
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pathogens
Subjects:
pan-ebolavirus
MBP134
immunotherapeutic
Sudan
SUDV
EBOV
Online Access:https://www.mdpi.com/2076-0817/11/6/655

Internet

https://www.mdpi.com/2076-0817/11/6/655

Similar Items